Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: All that I can say is that IF Brian's

I think a buyout would need shareholder approval. I wouldn't be voting for less than 50/60 cents a share. I also think that if they (management) could pull it off without shareholder approval that would be grounds for a heavy duty class action suit by the shareholders. And I think we'd win.

GL

Share
New Message
Please login to post a reply